financetom
Business
financetom
/
Business
/
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: XPeng Shares Rise After Q1 Non-GAAP Loss Narrows, Revenue Increases
May 21, 2024 7:32 AM

10:14 AM EDT, 05/21/2024 (MT Newswires) -- (Updates with the latest stock price movement in the headline and first paragraph.)

XPeng ( XPEV ) shares were up nearly 13% in recent Tuesday trading after the company's Q1 non-GAAP loss narrowed year-over-year while revenue rose.

The company reported a Q1 non-GAAP net loss of 1.49 Chinese renminbi ($0.21) per diluted American depositary share, narrowing from the non-GAAP net loss of 2.57 renminbi per ADS a year earlier.

Three analysts polled by Capital IQ expected a non-GAAP net loss of 1.77 renminbi per ADS.

Revenue for the quarter ended March 31 was 6.55 billion renminbi, up from 4.03 billion renminbi a year earlier.

Four analysts polled by Capital IQ expected 6.41 billion renminbi.

The company said it expects Q2 revenue of 7.5 billion renminbi to 8.3 billion renminbi. Analysts polled by Capital IQ expect 10.65 billion renminbi.

Price: 9.35, Change: +1.07, Percent Change: +12.91

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment
BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment
Aug 27, 2025
06:37 AM EDT, 08/27/2025 (MT Newswires) -- BeOne Medicines ( ONC ) said Wednesday that the European Commission has approved Tevimbra, in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by Tevimbra alone after surgery, for adults with resectable non-small cell lung cancer at high risk of recurrence. The company said the approval is based on the final analysis...
Market Chatter: UnitedHealth Probed By DOJ Over Prescription Management Services, Doctors' Reimbursement
Market Chatter: UnitedHealth Probed By DOJ Over Prescription Management Services, Doctors' Reimbursement
Aug 27, 2025
06:32 AM EDT, 08/27/2025 (MT Newswires) -- UnitedHealth ( UNH ) is being investigated by the US Justice Department's criminal division over the insurer's prescription management services and how it reimburses its own doctors, Bloomberg reported Wednesday. New details from the investigation show that the ambit of the probe goes beyond previously disclosed alleged Medicare fraud, the report said. The...
Profit dives at China's top food delivery firm Meituan amid intense competition
Profit dives at China's top food delivery firm Meituan amid intense competition
Aug 27, 2025
* Adjusted net profit falls 89% in second quarter * Meituan ( MPNGF ) faces fierce competition from JD.com ( JD ) and Alibaba ( BABA ) * Overseas expansion is accelerating (Adds details of international business in paragraph 10-11; adds analyst comment in paragraph 8.) By Casey Hall SHANGHAI, Aug 27 (Reuters) - China's leading food delivery group Meituan...
Ford to Recall More Than 355,000 Trucks Over Instrument Panel Display Issue
Ford to Recall More Than 355,000 Trucks Over Instrument Panel Display Issue
Aug 27, 2025
06:35 AM EDT, 08/27/2025 (MT Newswires) -- Ford Motor ( F ) is recalling up to 355,656 trucks in the US due to potential instrument panel display failure, the National Highway Traffic Safety Administration said in a recall notice Tuesday. The recall covers certain 2025-2026 models of the F-550 SD, F-450 SD, F-350 SD, and F-250 SD, as well as...
Copyright 2023-2025 - www.financetom.com All Rights Reserved